Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001574235

PULM

Pulmatrix, Inc.
$1.58 ▲ +2.60%
Prev close $1.54
Market cap$5.6M
High Impact Filing (7/10) Biotech & Drug Discovery
Snapshot
The big-picture read on PULM right now — valuation, ownership and activity at a glance.
Market Cap
$5.6M
Cap Size
Nano Cap
Inst. Holders
12 funds
Inst. Value
$463.1K
Inst. Activity
1 buys / 1 sells
Social Sentiment
40° Cool
SEC Reports
8
Press Releases
1
Price chart 30d +7.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
DateFirmActionRatingFirm rating
Aug 15, 2023HC Wainwright & Co.REITERATEBuy 43%
May 15, 2023HC Wainwright & Co.REITERATEBuy 43%
Feb 7, 2023HC Wainwright & Co.REITERATEBuy 43%
Mar 30, 2022HC Wainwright & Co.MAINTAINBuy 43%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Mar 1, 20252410086%
Feb 1, 20252410086%
Jan 1, 20252410086%
Dec 1, 20242410086%
Social media sentiment
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
40°
Cool
BearishNeutralBullish
1 mentions 0 bullish 1 bearish 0 neutral
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
8 SEC filing reports analyzed · 0 bullish, 3 bearish, 0 mixed, 5 neutral · avg impact 4.5/10.Plus 1 press releases.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 13, 2026
m_and_a
Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX FRAMINGHAM, Mass., Aug. 13, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatr
Aug 12, 2026
earnings_calendar
PULM Q2 2026 Earnings Scheduled — 2026-08-12
Aug 4, 2026
earnings_calendar
PULM Q2 2026 Earnings Scheduled — 2026-08-04
May 13, 2026
earnings_calendar
PULM Q1 2026 Earnings Scheduled — 2026-05-13
May 8, 2026
earnings_calendar
PULM Q1 2026 Earnings Scheduled — 2026-05-08
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.00$0.00–$0.00———$0.0B—
Next Q$0.00$0.00–$0.00———$0.0B—
Current FY$0.00$0.00–$0.00———$0.0B—
Next FY$0.00$0.00–$0.00———$0.0B—
Institutional ownership
Which big funds own PULM (from quarterly 13F filings) and who is adding or trimming.
12 institutional holders with $463.1K total value (272,398 shares) as of 2026-Q2. Top holders: ROYAL, RENAISSANCE, BlackRock,.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
ROYAL BANK OF CANADA7$0.000.0%—
RENAISSANCE TECHNOLOGIES LLC122,698$208.6K45.0%—
BlackRock, Inc.54,899$93.3K20.2%—
GEODE CAPITAL MANAGEMENT, LLC33,299$56.6K12.2%TRIM -25.4%
VANGUARD CAPITAL MANAGEMENT LLC32,294$54.9K11.9%—
VANGUARD FIDUCIARY TRUST CO14,715$25.0K5.4%—
STATE STREET CORP13,945$23.7K5.1%—
UBS Group AG515$875.000.2%DOUBLED +2139.1%
BARCLAYS PLC15$26.000.0%—
Farther Finance Advisors, LLC7$12.000.0%—
Recent position changes
FundActionPrevCurrentChangeValue
GEODE CAPITAL MANAGEMENT, LLCTRIM44,62933,299-25.4%$56.6K
UBS Group AGDOUBLED23515+2139.1%$875.00
BANK OF AMERICA CORP /DE/DOUBLED331,365+4036.4%$3.0K
NORTHWESTERN MUTUAL WEALTH MANAGEMENT COADD713+85.7%$2.2K
UBS Group AGNEAR_EXIT5,463129-97.6%$627.00
UBS Group AGDOUBLED1,1555,463+373.0%$37.7K
UBS Group AGNEAR_EXIT4,9201,155-76.5%$7.7K
UBS Group AGDOUBLED3924,920+1155.1%$34.3K
BANK OF AMERICA CORP /DE/ADD3038+26.7%$81.00
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PULM.
Shares short
55,391
Settlement Sep 15, 2026
Change vs prior
+174.2%
Semi-monthly cycle
Days to cover
1.3
At avg daily volume
Of shares outstanding
≈1.5%
Estimate — not % of float
All PULM filing & press-release reports (9)